ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Accelerating antibiotic discovery through artificial intelligence

Melo, Marcelo C. R.; Maasch, Jacqueline R. M. A.; de la Fuente-Nunez, Cesar*
Communications Biology2021-9-9DOI: 10.1038/s42003-021-02586-0
94被引9阅读
引用收藏
分享

摘要

By targeting invasive organisms, antibiotics insert themselves into the ancient struggle of the host-pathogen evolutionary arms race. As pathogens evolve tactics for evading antibiotics, therapies decline in efficacy and must be replaced, distinguishing antibiotics from most other forms of drug development. Together with a slow and expensive antibiotic development pipeline, the proliferation of drug-resistant pathogens drives urgent interest in computational methods that promise to expedite candidate discovery. Strides in artificial intelligence (AI) have encouraged its application to multiple dimensions of computer-aided drug design, with increasing application to antibiotic discovery. This review describes AI-facilitated advances in the discovery of both small molecule antibiotics and antimicrobial peptides. Beyond the essential prediction of antimicrobial activity, emphasis is also given to antimicrobial compound representation, determination of drug-likeness traits, antimicrobial resistance, and de novo molecular design. Given the urgency of the antimicrobial resistance crisis, we analyze uptake of open science best practices in AI-driven antibiotic discovery and argue for openness and reproducibility as a means of accelerating preclinical research. Finally, trends in the literature and areas for future inquiry are discussed, as artificially intelligent enhancements to drug discovery at large offer many opportunities for future applications in antibiotic development. Melo, Maasch and de la Fuente-Nunez review the current practices in use of artificial intelligence in the discovery of antibiotics and antimicrobials. They also provide details about the best-practices that should be engaged with during computational drug discovery, including open science and reproducibility.

学科与关键词

关键词
SUBSTRATE CLEAVAGE SITESANTIMICROBIAL PEPTIDESWEB SERVERLEARNING APPROACHDRUG DISCOVERYSEQUENCE SPACEMACHINEPREDICTIONGENERATIONDESIGN
相关
加载中…
  • Antibiotic discovery in the artificial intelligence era
    Lluka, Telmah; Stokes, Jonathan M.*Annals of the New York Academy of Sciences, 2023, 1519(1): 74-93.被引 14
  • Applying Machine Learning for Antibiotic Development and Prediction of Microbial Resistance
    Panjla, Apurva; Joshi, Saurabh; Singh, Geetanjali; Bamford, Sarah E.; Mechler, Adam; Verma, Sandeep*Chemistry - An Asian Journal, 2024, 19(18).
  • Deep learning tools to accelerate antibiotic discovery
    Cesaro, Angela; Bagheri, Mojtaba; Torres, Marcelo; Wan, Fangping; de la Fuente-Nunez, Cesar*Expert Opinion on Drug Discovery, 2023.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Communications Biology
发表日期
2021-09-09
卷期
第 4 卷, 第 1 期
页码
1050
DOI
10.1038/s42003-021-02586-0
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Institute for Diabetes, Obesity, and Metabolism; Penn Mental Health AIDS Research Center of the University of Pennsylvania; Nemirovsky Prize; Perelman School of Medicine at the University of Pennsylvania; National Institute of General Medical Sciences of the National Institutes of Health [R35GM138201]; Defense Threat Reduction Agency (DTRA) [HDTRA11810041, HDTRA1-21-1-0014]; University of Pennsylvania GAPSA-Provost Fellowship; Open Knowledge Foundation Frictionless Data for Reproducible Research Fellowship - Alfred P. Sloan Foundation

作者

  • M

    Melo, Marcelo C. R. (第一作者)

  • M

    Maasch, Jacqueline R. M. A.

查看全部 3 位作者收起作者
  • d

    de la Fuente-Nunez, Cesar (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417